David M. Cohen

Characterization of the Clinical Evidence Supporting Repository Corticotropin Injection for FDA-Approved Indications: A Scoping Review.

Daniel M. Hartung, D. Bourdette, A. Deodhar, 2021, JAMA internal medicine.

Modeling the Neurologic and Cognitive Effects of Hyponatremia.

D. Cohen, David M. Cohen, 2016, Journal of the American Society of Nephrology : JASN.

A mutation creating an out‐of‐frame alternative translation initiation site in the GRHPR 5′UTR causing primary hyperoxaluria type II

Y. Fu, D. Cohen, R. Holmes, 2015, Clinical genetics.

Heritability and individuality of the plasma sodium concentration: a twin study in the United States veteran population.

J. Goldberg, N. Smith, D. Cohen, 2019, American journal of physiology. Renal physiology.

Heritability of serum sodium concentration: evidence for sex- and ethnic-specific effects.

S. McWeeney, S. Cole, James G. Wilson, 2012, Physiological genomics.

Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin

Daniel M. Hartung, D. Bourdette, A. Deodhar, 2018, JAMA network open.

Trends and Characteristics of US Medicare Spending on Repository Corticotropin

Daniel M. Hartung, D. Bourdette, A. Deodhar, 2017, JAMA internal medicine.

NFAT5 and SLC4A10 Loci Associate with Plasma Osmolality.

M. P. Concas, Toshiko Tanaka, J. Murabito, 2017, Journal of the American Society of Nephrology : JASN.

The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis.

Daniel B. Putterman, P. Steyger, L. Hunter, 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.